Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K/A |
Revenues: |
Long-Term Care | | | | 3,539.4 |
Hospice and Home Health | | | | 526.3 |
Other | | | | 79.8 |
Total revenues [+] | 318.5 | 471.2 | 575.8 | 4,145.5 |
Tenant reimbursements | 1.3 | 1.5 | 1.5 | |
Lease / rental | 317.2 | 469.7 | 574.3 | |
Revenue growth | -32.4% | -18.2% | -86.1% | |
Cost of goods sold | 2.4 | 3.7 | 3.7 | 3,423.4 |
Gross profit | 316.1 | 467.5 | 572.1 | 722.1 |
Gross margin | 99.2% | 99.2% | 99.4% | 17.4% |
Selling, general and administrative [+] | 27.2 | 22.1 | 23.9 | 149.5 |
General and administrative | 27.2 | 22.1 | 23.9 | 149.5 |
Equity in earnings | | | 34.5 | |
Other operating expenses | 0.9 | 24.4 | -37.5 | -4.3 |
EBITDA [+] | 288.0 | 421.0 | 620.2 | 578.0 |
EBITDA growth | -31.6% | -32.1% | 7.3% | |
EBITDA margin | 90.4% | 89.4% | 107.7% | 13.9% |
Depreciation | 131.6 | 165.6 | 244.6 | 144.0 |
EBITA | 156.4 | 255.5 | 375.6 | 434.0 |
EBITA margin | 49.1% | 54.2% | 65.2% | 10.5% |
Amortization of intangibles | 0.0 | 0.0 | 0.0 | |
EBIT [+] | 156.4 | 255.5 | 375.6 | 434.0 |
EBIT growth | -38.8% | -32.0% | -13.5% | |
EBIT margin | 49.1% | 54.2% | 65.2% | 10.5% |
Non-recurring items [+] | 464.2 | 167.1 | 227.4 | 201.7 |
Asset impairment | 445.7 | 167.1 | 227.4 | 203.1 |
Loss (gain) on sale of assets | | | | -1.4 |
Interest expense | 140.5 | 25.0 | | 406.9 |
Interest expense | 140.5 | 25.0 | | 406.9 |
Other income (expense), net [+] | 2.8 | 0.3 | -35.8 | |
Impairment of equity method investments | | | -35.9 | |
Other | 2.8 | 0.3 | 0.1 | |
Pre-tax income | -445.5 | 63.7 | 112.4 | -174.5 |
Income taxes | -2.1 | -17.5 | -0.8 | 210.4 |
Tax rate | 0.5% | | | |
Minority interest | 0.1 | | | -0.4 |
Earnings from continuing ops | -443.8 | 81.1 | 113.2 | -384.9 |
Earnings from discontinued ops | | | | -9.0 |
Net income | -443.8 | 81.1 | 113.2 | -393.9 |
Net margin | -139.4% | 17.2% | 19.7% | -9.5% |
|
Basic EPS [+] | ($4.74) | $0.87 | $1.21 | |
Growth | -646.9% | -28.3% | | |
Diluted EPS [+] | ($4.74) | $0.87 | $1.21 | |
Growth | -646.9% | -28.3% | | |
|
Dividends per share [+] | $0.00 | $4.73 | $7.30 | |
Growth | -99.9% | -35.2% | | |
|
Shares outstanding (basic) [+] | 93.6 | 93.6 | 93.6 | |
Growth | 0.0% | 0.0% | | |
Shares outstanding (diluted) [+] | 93.6 | 93.6 | 93.6 | |
Growth | 0.0% | 0.0% | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|